Atlas Trials

Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenicity

Clinical trial NCT00772954 · TERMINATED

Trial details

NCT number
NCT00772954
Sponsor
Sanofi
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Clostridium Difficile InfectionClostridium Difficile Diarrhea
Start date
2006-03-01
Primary completion
2006-06-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.